Dr. Reddy's Launches Celadrin as Pharma Product

Imagenetix, Inc., the developer of Celadrin announced that it has tied up with Cymbiotics, Inc. and Dr. Reddy's Laboratories Ltd., to launch the product in India. Celadrin is a proprietary fatty acid complex useful in promoting the health of joints and is used by physicians in the treatment of patients with osteoarthritis. Celadrin has been approved for use as a pharmaceutical product in India to help reduce pain and inflammation in patients with joint problems. In the U.S., Celadrin is currently available in oral form as a dietary supplement and as an over-the-counter topical cream at food, drug and mass retail stores.

Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=78392bf4a5e9d14b&cat=6dcd932030878143)